Long-Term Effect of Natalizumab in Patients With Relapsing–Remitting Multiple Sclerosis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Multiple Sclerosis (Houndmills, Basingstoke, England)
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Long-Term Effect of Natalizumab in Patients With RRMS: TYSTEN Cohort
Mult. Scler. 2021 Apr 01;27(5)729-741, K Bigaut, T Fabacher, L Kremer, JC Ongagna, A Kwiatkowski, F Sellal, D Ferriby, S Courtois, P Vermersch, N Collongues, H Zéphir, J De Seze, O OutteryckFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.